Tsukuba, Japan

Keiko Ohga

USPTO Granted Patents = 2 


Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 70(Granted Patents)


Company Filing History:


Years Active: 2008-2011

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Keiko Ohga: Innovator in Respiratory Disease Treatment

Introduction

Keiko Ohga is a prominent inventor based in Tsukuba, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating respiratory diseases. With a total of two patents to her name, her work is recognized for its potential impact on public health.

Latest Patents

Keiko Ohga's latest patents include a diaminopyrimidinecarboxamide derivative. This compound may be used for the prevention or treatment of respiratory diseases in which STAT 6 is concerned, particularly asthma and chronic obstructive pulmonary disease. The patent describes a pyrimidine derivative or a salt thereof, which features an arylamino or arylethylamino group that may be substituted with a specified substituent at the 2-position. Additionally, it includes an amino group substituted with a benzyl group or the like at the 4-position, and a carbamoyl group that may be substituted at the 5-position.

Career Highlights

Keiko Ohga is currently employed at Astellas Pharma GmbH, where she continues to innovate in the pharmaceutical industry. Her work focuses on developing new treatments that can significantly improve the quality of life for patients suffering from respiratory conditions.

Collaborations

Some of her notable coworkers include Shinya Nagashima and Hiroshi Nagata, who collaborate with her on various projects within the company.

Conclusion

Keiko Ohga's contributions to the field of respiratory disease treatment through her innovative patents highlight her role as a key inventor in the pharmaceutical industry. Her work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…